Takahiro Nishio

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Top Venues

Annals of gastroenterological surgery

Proceedings of the National Academy of Sciences of the United States of America

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

This page only lists publications with an associated author ORCID identifier.

Publications

Takahiro Nishio, Kojiro Taura, Yukinori Koyama, Takamichi Ishii, Etsuro Hatano
Current status of preoperative risk assessment for posthepatectomy liver failure in patients with hepatocellular carcinoma. Annals of gastroenterological surgery 7 (6) (2023)
Takahiro Nishio, Takashi Ito, Koichiro Hata, Kojiro Taura, Etsuro Hatano
Current status of liver transplantation for non-B non-C liver cirrhosis and hepatocellular carcinoma. Annals of gastroenterological surgery 7 (1) (2022)
Takahiro Nishio, Takashi Ito, Koichiro Hata, Kojiro Taura, Etsuro Hatano
Current status of liver transplantation for non-B non-C liver cirrhosis and hepatocellular carcinoma. Annals of gastroenterological surgery 7 (1) (2022)
Nguyen Hai Nam, Kojiro Taura, Yukinori Koyama, Takahiro Nishio, Gen Yamamoto, Yusuke Uemoto, Yusuke Kimura, Li Xuefeng, Daichi Nakamura, Kenji Yoshino, Eri Ogawa, Tatsuya Okamoto, Atsushi Yoshizawa, Satoru Seo, Keiko Iwaisako, Tomoaki Yoh, Koichiro Hata, Toshihiko Masui, Hideaki Okajima, Hironori Haga, Shinji Uemoto, Etsuro Hatano
Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
Brian Rady, Takahiro Nishio, Debanjan Dhar, Xiao Liu, Mark Erion, Tatiana Kisseleva, David A Brenner, Alessandro Pocai
PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells. PloS one 16 (12) (2021)
Takahiro Nishio, Yukinori Koyama, Xiao Liu, Sara B Rosenthal, Gen Yamamoto, Hiroaki Fuji, Jacopo Baglieri, Na Li, Laura N Brenner, Keiko Iwaisako, Kojiro Taura, James S Hagood, Nicholas F LaRusso, Tapan K Bera, Ira H Pastan, David A Brenner, Tatiana Kisseleva
Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis. Proceedings of the National Academy of Sciences of the United States of America 118 (29) (2021)